Vertex Pharmaceuticals Inc / Ma
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 6,591 | 0.2% | 14,538 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 4,754 | 0.1% | 12,138 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 11,146 | 0.3% | 25,036 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 15,030 | 0.4% | 31,001 | 3/31/2025 |
| 2024 Q4 | 2/13/2025 | 12,856 | 0.4% | 31,924 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 12,135 | 0.3% | 26,093 | 9/30/2024 |
| 2024 Q2 | 8/8/2024 | 14,208 | 0.3% | 30,312 | 6/30/2024 |
| 2024 Q1 | 5/9/2024 | 22,854 | 0.5% | 54,674 | 3/31/2024 |
| 2023 Q4 | 2/9/2024 | 29,386 | 0.6% | 72,220 | 12/31/2023 |
| 2023 Q3 | 11/2/2023 | 21,152 | 0.5% | 60,826 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 21,405 | 0.4% | 60,826 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 19,205 | 0.4% | 60,956 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 15,188 | 0.4% | 52,594 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 15,228 | 0.4% | 52,594 | 9/30/2022 |
| 2022 Q2 | 8/12/2022 | 14,894 | 0.3% | 52,854 | 6/30/2022 |
| 2022 Q1 | 5/13/2022 | 26,736 | 0.4% | 102,447 | 3/31/2022 |
| 2021 Q4 | 2/11/2022 | 22,488 | 0.3% | 102,404 | 12/31/2021 |
| 2021 Q3 | 11/4/2021 | 21,840 | 0.3% | 120,404 | 9/30/2021 |
| 2021 Q2 | 8/13/2021 | 23,459 | 0.3% | 116,347 | 6/30/2021 |
| 2021 Q1 | 5/13/2021 | 18,555 | 0.3% | 86,347 | 3/31/2021 |
| 2020 Q4 | 2/11/2021 | 21,705 | 0.3% | 91,840 | 12/31/2020 |
| 2020 Q3 | 11/12/2020 | 17,475 | 0.3% | 64,217 | 9/30/2020 |
| 2020 Q2 | 8/12/2020 | 16,110 | 0.4% | 55,491 | 6/30/2020 |
| 2020 Q1 | 5/8/2020 | 5,122 | 0.2% | 21,526 | 3/31/2020 |
| 2019 Q4 | 2/13/2020 | 4,416 | 0.1% | 20,167 | 12/31/2019 |